Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

SANDOZ ALFACALCIDOL DIN 02533316

Status: Marketed
Holder: SANDOZ CANADA INCORPORATED
Molecule: ALFACALCIDOL
Available to quote

Health Canada record

Active ingredient(s)ALFACALCIDOL 0.25 MCG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCA11CC03 ALFACALCIDOL
Original market date24-Apr-2023
Current status date24-Apr-2023
SourceHealth Canada DPD

Establishment licence of the holder

Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ALFACALCIDOL

DINProductCompanyFormStrengthStatus
02523078ALFACALCIDOL CAPSULESSTRIDES PHARMA CANADA INCCapsuleALFACALCIDOL 1 MCGApproved
02523051ALFACALCIDOL CAPSULESSTRIDES PHARMA CANADA INCCapsuleALFACALCIDOL 0.25 MCGApproved
02240329ONE-ALPHACHEPLAPHARM ARZNEIMITTEL GMBHDropsALFACALCIDOL 2 MCGMarketed
02242502ONE-ALPHACHEPLAPHARM ARZNEIMITTEL GMBHSolutionALFACALCIDOL 2 MCGMarketed
00474517ONE-ALPHACHEPLAPHARM ARZNEIMITTEL GMBHCapsuleALFACALCIDOL 0.25 MCGMarketed
00474525ONE-ALPHACHEPLAPHARM ARZNEIMITTEL GMBHCapsuleALFACALCIDOL 1 MCGMarketed
02533324SANDOZ ALFACALCIDOLSANDOZ CANADA INCORPORATEDCapsuleALFACALCIDOL 1 MCGMarketed
02239431ONE-ALPHALEO PHARMA INCCapsuleALFACALCIDOL 0.5 MCGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
296662022-12-09Abbreviated New Drug Submission (ANDS)Administrative: Licensing Agreement Between Two Companies

International API supply for ALFACALCIDOL

6 valid EDQM Certificates of Suitability from 6 holders.

Request a quote for SANDOZ ALFACALCIDOL

How to read a Canadian DIN record